Lynch Regenerative Medicine Completes Phase II Wound Trial
FRANKLIN, Tenn., August 18, 2026 Lynch Regenerative Medicine (LRM) announced the completion of enrollment in an investigator-initiated Phase II...
skin cancer
Advertisement
Natera, Inc. and Kupando Therapeutics Launch Phase 1 Study to Monitor ctDNA in Advanced Skin Cancers
AUSTIN, Texas, August 12, 2026 Natera, Inc. announced a new collaboration with Kupando Therapeutics to support a Phase 1...
Regeneron Expands Libtayo Approval for High-Risk CSCC
Toronto, Ontario, Canada, August 8, 2026 Regeneron Canada Company announced that Health Canada has approved Libtayo® (cemiplimab for injection)...
bioAffinity Technologies Reports CyPath Lung Growth
SAN ANTONIO, Texas, August 7, 2026 bioAffinity Technologies reported second quarter 2026 financial results highlighted by continued commercial momentum...
Natera Reports Signatera Superior to AMERK in MCC Monitoring
AUSTIN, Texas, July 22, 2026 Natera announced the publication of a prospective, multicenter study in JAMA Dermatology demonstrating that...
Advertisements
Alpha Tau Enrolls First Immunocompromised Patient in ADMIRE
JERUSALEM, July 15, 2026 Alpha Tau Medical announced the successful treatment of the first patient in its ADMIRE clinical...
Phio Pharmaceuticals Showcases PH-762 Skin Cancer Trial Progress
KING OF PRUSSIA, Pa., May 12, 2026 Phio Pharmaceuticals announced that company leadership will participate in a virtual fireside...
Alpha Tau Completes Enrollment in Pivotal ReSTART cSCC Study
JERUSALEM, May 8, 2026 Alpha Tau Medical Ltd. announced the completion of patient enrollment in its ReSTART pivotal clinical...
Phio Pharmaceuticals Reports Positive PH-762 Skin Cancer Data
KING OF PRUSSIA, PENNSYLVANIA, March 23, 2026 Phio Pharmaceuticals Corp. has announced the presentation of positive clinical study results...
Phio Pharmaceuticals Advances siRNA Immunotherapy in Skin Cancer with INTASYL PH-762
Dateline — King of Prussia, Pennsylvania, November 7, 2025:Phio Pharmaceuticals Corp. (NASDAQ: PHIO) has announced new clinical data from...
Advertisement
